Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer
Stuthi Perimbeti(Roswell Park Comprehensive Cancer Center), Gurkamal Chatta(Roswell Park Comprehensive Cancer Center)
Cited by 4
Related Papers
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
|New England Journal of Medicine|2024|145